Showing results (31-40 of 201) with videos related to
Sort By:
Pageof 21
Neuropharmacology|August 1, 1991
Spironolactone causes a rapid down regulation of sigma recognition sites in guinea pig brain and liverA R Knight, C Wyatt, D N MiddlemissEuropean Journal of Pharmacology|July 4, 1998
Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regionsC Roberts, A Belenguer, D N Middlemiss, et al.European Journal of Pharmacology|November 15, 1988
A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortexD N Middlemiss, M E Bremer, S M SmithBritish Journal of Pharmacology|August 1, 1995
Relationship between inhibition of cyclic AMP production in Chinese hamster ovary cells expressing the rat D2(444) receptor and antagonist/agonist binding ratiosE A Harley, D N Middlemiss, C I RaganNeuropharmacology|February 1, 1996
Autoradiographic localization of 5-CT-insensitive 5-HT1-like recognition sites in guinea pig and rat brainJ A Stanton, D N Middlemiss, M S BeerJournal of Cardiovascular Pharmacology|March 1, 1987
Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysisJ R Fozard, A K Mir, D N MiddlemissNeuroscience Letters|August 14, 1990
The TRH analogue MK-771, increases acetylcholine release in hippocampus but not striatum of the conscious ratP H Hutson, J E Semark, D N MiddlemissThe Journal of Pharmacy and Pharmacology|January 1, 1982
Stereospecificity of behavioural effects of viloxazine in bulbectomized rats does not correlate with its 5-HT-releasing action in vitroD T Greenwood, J D Kemp, D N MiddlemissThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1994
5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivoL O Wilkinson, D N Middlemiss, P H HutsonLife Sciences|August 6, 1984
"Calcium antagonists": a class of drugs with a bright future. Part II. Determination of basic pharmacological propertiesM Spedding, I CaveroPageof 21